Morgan Stanley Aktie
WKN: 885836 / ISIN: US6174464486
|
10.12.2024 15:23:32
|
Morgan Stanley Capital Partners To Acquire Prescott's To Expand Healthcare Portfolio
(RTTNews) - Investment funds managed by Morgan Stanley Capital Partners (MSCP), the middle-market focused private equity team at Morgan Stanley Investment Management, on Tuesday agreed to acquire Prescott's, a healthcare focused specialty outsourced clinical engineering services provider, from Atlantic Street Capital. Closing is subject to customary closing conditions.
MSCP is partnering with the current management team led by CEO Brian Straeb, who will continue to lead the business.
Prescott's provides medical equipment repair and maintenance service solutions, alongside refurbished equipment and parts sales and rentals for critical surgical suite modalities including microscopes, infusion pumps, patient monitors, anesthesia machines and sterilizers.
Monument, Colorado-based Prescott's serves health systems, outpatient facilities and other care settings across the United States and the UK.
MSCP's acquisition of Prescott's will be its fourth investment in the Healthcare Outsourced Services sector.
Since 2019, MSCP has invested in health plan communications solutions provider, Clarity Software Solutions, pharma education and marketing solutions provider, US HealthConnect and health system cost cycle management provider, SpendMend.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Morgan Stanleymehr Nachrichten
|
17.10.25 |
S&P 500-Wert Morgan Stanley-Aktie: So viel Gewinn hätte ein Investment in Morgan Stanley von vor einem Jahr abgeworfen (finanzen.at) | |
|
15.10.25 |
Börse New York: So entwickelt sich der S&P 500 am Nachmittag (finanzen.at) | |
|
15.10.25 |
Gute Stimmung in New York: So performt der S&P 500 am Mittwochmittag (finanzen.at) | |
|
15.10.25 |
Mittwochshandel in New York: S&P 500 zum Handelsstart in Grün (finanzen.at) | |
|
15.10.25 |
Morgan Stanley overtakes arch-rival Goldman Sachs in equities trading (Financial Times) | |
|
15.10.25 |
Morgan Stanley overtakes arch-rival Goldman Sachs in equities trading (Financial Times) | |
|
15.10.25 |
Ausblick: Morgan Stanley stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) | |
|
10.10.25 |
S&P 500-Wert Morgan Stanley-Aktie: So viel Gewinn hätte ein Investment in Morgan Stanley von vor 10 Jahren abgeworfen (finanzen.at) |
Analysen zu Morgan Stanleymehr Analysen
| 16.07.24 | Morgan Stanley Neutral | UBS AG |
Aktien in diesem Artikel
| Morgan Stanley | 137,12 | 0,81% |
|